RC
BOLD

RBF Capital’s Boundless Bio BOLD Stock Holding History

RBF Capital’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$500K Hold
200,000
– – 0.02% 387
2026
Q1 		$220K Hold
200,000
– – 0.01% 450
2025
Q4 		$240K Hold
200,000
– – 0.01% 499
2025
Q3 		$246K Hold
200,000
– – 0.01% 501
2025
Q2 		$202K Buy
+200,000
New +$266K 0.01% 536

Other funds holding BOLD

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

RBF Capital's BOLD Position: Q2 2026 in Review

RBF Capital held its Boundless Bio (BOLD) position steady in Q2 2026 at 200,000 shares worth $500K. The position accounts for 0.02% of the portfolio, ranked #387.

RBF Capital first reported a position in BOLD in Q2 2025 and has held it in 5 quarters since. 40 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

  • RBF Capital held 200,000 shares of Boundless Bio worth $500K as of Q2 2026.
  • RBF Capital left its Boundless Bio share count unchanged in Q2 2026.
  • Boundless Bio made up 0.02% of RBF Capital's portfolio in Q2 2026, its #387 holding.
  • RBF Capital first reported a position in Boundless Bio in Q2 2025 and has held it in 5 quarters since.
  • 40 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on RBF Capital's 13F filing for Q2 2026, filed 14 Aug 2026.